XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Basis of Presentation (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Apr. 04, 2022
USD ($)
shares
Sep. 29, 2023
USD ($)
Jun. 30, 2023
$ / shares
Mar. 31, 2023
$ / shares
Sep. 30, 2022
USD ($)
Jul. 01, 2022
$ / shares
Apr. 01, 2022
USD ($)
Sep. 29, 2023
USD ($)
segment
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Nov. 30, 2022
shares
Concentration Risk [Line Items]                      
Number of reportable segments | segment               2      
Quarterly cash dividend declared (in dollars per share) | $ / shares     $ 0.06 $ 0.05   $ 0.05          
Payment of dividends               $ 9,702 $ 3,025    
Net income   $ 57,570     $ 52,354     155,046 163,040    
Cumulative translation loss   (1,500,809)           (1,500,809)   $ (1,350,207)  
Research and development expense   9,000     $ 8,000     28,100 $ 27,100    
Former Partner                      
Concentration Risk [Line Items]                      
Allocated expenses             $ 6,000        
Foreign Currency Translation Adjustment                      
Concentration Risk [Line Items]                      
Cumulative translation loss   125,000           125,000      
Enovis Corporation                      
Concentration Risk [Line Items]                      
Number of shares sold | shares                     6,000,000
Russia                      
Concentration Risk [Line Items]                      
Net income   $ 3,000           $ 10,000      
Russia | Assets | Geographic Concentration Risk                      
Concentration Risk [Line Items]                      
Concentration risk (as a percent)               4.00%      
Russia | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk                      
Concentration Risk [Line Items]                      
Concentration risk (as a percent)   5.00%                  
Enovis Corporation                      
Concentration Risk [Line Items]                      
Cash consideration $ 1,200,000                    
ESAB Corporation | Enovis Corporation                      
Concentration Risk [Line Items]                      
Ownership (as a percent) 10.00%                    
Common Stock                      
Concentration Risk [Line Items]                      
Percentage of outstanding stock after spin-off (as a percent) 90.00%                    
Common Stock | Enovis Corporation                      
Concentration Risk [Line Items]                      
Number of shares recapitalized (in shares) | shares 3                    
Common Stock | ESAB Corporation | Enovis Corporation                      
Concentration Risk [Line Items]                      
Number of shares received (in shares) | shares 1